TY - JOUR
T1 - Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children
T2 - 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
AU - McDonald, L. Clifford
AU - Gerding, Dale N.
AU - Johnson, Stuart
AU - Bakken, Johan S.
AU - Carroll, Karen C.
AU - Coffin, Susan E.
AU - Dubberke, Erik
AU - Garey, Kevin W.
AU - Gould, Carolyn V.
AU - Kelly, Ciaran
AU - Loo, Vivian
AU - Shaklee Sammons, Julia
AU - Sandora, Thomas J.
AU - Wilcox, Mark H.
PY - 2018/3/19
Y1 - 2018/3/19
N2 - A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults. The update, which has incorporated recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment), includes significant changes in the management of this infection and reflects the evolving controversy over best methods for diagnosis. Clostridium difficile remains the most important cause of healthcare-associated diarrhea and has become the most commonly identified cause of healthcare-associated infection in adults in the United States. Moreover, C. difficile has established itself as an important community pathogen. Although the prevalence of the epidemic and virulent ribotype 027 strain has declined markedly along with overall CDI rates in parts of Europe, it remains one of the most commonly identified strains in the United States where it causes a sizable minority of CDIs, especially healthcare-associated CDIs. This guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management.
AB - A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults. The update, which has incorporated recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment), includes significant changes in the management of this infection and reflects the evolving controversy over best methods for diagnosis. Clostridium difficile remains the most important cause of healthcare-associated diarrhea and has become the most commonly identified cause of healthcare-associated infection in adults in the United States. Moreover, C. difficile has established itself as an important community pathogen. Although the prevalence of the epidemic and virulent ribotype 027 strain has declined markedly along with overall CDI rates in parts of Europe, it remains one of the most commonly identified strains in the United States where it causes a sizable minority of CDIs, especially healthcare-associated CDIs. This guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management.
KW - CDAD
KW - CDI
KW - Clostridioides difficile
KW - Clostridium difficile
KW - Guidelines
UR - http://www.scopus.com/inward/record.url?scp=85044191899&partnerID=8YFLogxK
U2 - 10.1093/cid/cix1085
DO - 10.1093/cid/cix1085
M3 - Review article
C2 - 29462280
SN - 1058-4838
VL - 66
SP - e1-e48
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 7
ER -